Literature DB >> 1701783

Identification of an epitope of type 1 streptococcal M protein that is shared with a 43-kDa protein of human myocardium and renal glomeruli.

W Kraus1, J B Dale, E H Beachey.   

Abstract

The localization of opsonic and tissue-cross-reactive epitopes within the amino terminus of type 1 streptococcal M protein was investigated by using murine mAb raised against synthetic peptides of type 1 M protein. Two mAb (IIIA2 and IIIB8) reacted with epitopes located within amino acid residues 1-12 of type 1 M protein. These antibodies opsonized type 1 streptococci and did not cross-react with human kidney and heart tissue. Another mAb (IC7) reacted with mesangial cells of renal glomeruli and human myocardium. The cross-reactive epitope of mAb IC7 was localized to position 13-19, indicating that it is not the same epitope as the previously described vimentin-cross-reactive epitope at position 23-26 of type 1 M protein. In Western blots of mesangial cell and myocardial proteins, mAb IC7 cross-reacted with a 43-kDa protein. Neither vimentin nor actin inhibited the binding of mAb IC7 to the cross-reactive protein, as determined by Western blot or immunofluorescence inhibition tests. These results provide evidence that type 1 M protein contains at least one autoimmune epitope shared with both human glomeruli and myocardium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701783

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Molecular mimicry--hypothesis or reality?

Authors:  N Tsuchiya; R C Williams
Journal:  West J Med       Date:  1992-08

2.  Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.

Authors:  H Basma; A Norrby-Teglund; A McGeer; D E Low; O El-Ahmedy; J B Dale; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Autoantibodies from mixed cryoglobulinaemia patients bind glomerular antigens.

Authors:  M P Dolcher; B Marchini; A Sabbatini; G Longombardo; C Ferri; L Riente; S Bombardieri; P Migliorini
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.

Authors:  H Basma; A Norrby-Teglund; Y Guedez; A McGeer; D E Low; O El-Ahmedy; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients.

Authors:  M El-Demellawy; R El-Ridi; N I Guirguis; M Abdel Alim; A Kotby; M Kotb
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

Review 6.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

7.  Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study.

Authors:  K F Jones; S S Whitehead; M W Cunningham; V A Fischetti
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 8.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

9.  Long-term antibody memory induced by synthetic peptide vaccination is protective against Streptococcus pyogenes infection and is independent of memory T cell help.

Authors:  Manisha Pandey; Michelle N Wykes; Jon Hartas; Michael F Good; Michael R Batzloff
Journal:  J Immunol       Date:  2013-02-11       Impact factor: 5.422

10.  Characterization of a conserved helper-T-cell epitope from group A Streptococcal M proteins.

Authors:  J H Robinson; M C Case; M A Kehoe
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.